Clinical Trials in Pennsylvania

Showing 11141-11160 of 16,895 trials

The Effects of Sildenafil on Exercise Function and Capacity in Patients With Fontan Circulation

NCT00964782

The study will test the hypothesis that a single dose of sildenafil can increase the exercise capacity of pediatric patients with a Fontan Circulation.

Fontan Circulation

Milton S. Hershey Medical Center17 participantsStarted Aug 2009

Hershey, Pennsylvania, United States

COMPLETEDNA95 miles

FOLFOX Plus SIR-SPHERES MICROSPHERES Versus FOLFOX Alone in Patients With Liver Mets From Primary Colorectal Cancer

NCT00724503

This study is a randomized multi-center trial that will assess the effect of adding Selective Internal Radiation Therapy (SIRT), using SIR-Spheres microspheres®, to a standard chemotherapy regimen of FOLFOX as first line therapy in patients with non-resectable liver metastases from primary colorectal adenocarcinoma. Treatment with the biologic agent bevacizumab, if part of the standard of care at participating institutions, is allowed within this study at the discretion of the treating Investigator.

Colorectal CancerColorectal CarcinomaLiver Metastases

Sirtex Medical530 participantsStarted Aug 2006

Scottsdale, Arizona, United States • Duarte, California, United States • North Miami Beach, Florida, United States +108 more locations

The Effects of Sildenafil on Exercise Function and Capacity in Patients With Fontan Circulation

FOLFOX Plus SIR-SPHERES MICROSPHERES Versus FOLFOX Alone in Patients With Liver Mets From Primary Colorectal Cancer

Find Trials by Condition in Pennsylvania

Inappropriate Shock Reduction wIth PARAD+ Rhythm DiScrimination

Belinostat for Solid Tumors and Lymphomas in Patients With Varying Degrees of Hepatic Dysfunction

Antenatal Phenobarbital to Prevent Neonatal Intracranial Hemorrhage

Persistent Pulmonary Hypertension of the Newborn (PPHN) Observational Study

Exosurf Neonatal and Survanta for Treatment of Respiratory Distress Syndrome

The PLATINUM Clinical Trial to Assess the PROMUS Element Stent System for Treatment of Long De Novo Coronary Artery Lesions (PLATINUM LL)

A Phase I, Two-part Study to Determine the Recommended Dose and Evaluate the Safety and Tolerability of a Novel Oral Arsenic Trioxide Formulation (ORH-2014) in Subjects With Advanced Hematological Disorders

Immunogenicity of PCV-7 Vaccine in VLBW Infants

Early Diagnosis of Candidiasis in Premature Infants

Observational Study of Surgical Treatment of Necrotizing Enterocolotis

Whole-Body Cooling for Birth Asphyxia in Term Infants

LDK378 in Crizotinib naïve Adult Patients With ALK-activated Non-small Cell Lung Cancer

A Brief Educational Intervention to Improve Traumatic Brain Injury (TBI) Screening Outcomes

A Phase I/IIa Open-Label, Dose Escalation and Cohort Expansion Trial of Oral TSR-011 in Patients With Advanced Solid Tumors and Lymphomas

The PLATINUM Clinical Trial to Assess the PROMUS Element Stent System for Treatment of De Novo Coronary Artery Lesions in Small Vessels

Effects of AZD1775 on the PK Substrates for CYP3A, CYP2C19, CYP1A2 and on QT Interval in Patients With Advanced Cancer

PLATINUM Trial to Assess the PROMUS Element Stent System for Treatment of De Novo Coronary Artery Lesions-Pharmacokinetics (PLATINUM PK)

Phase IV EORTC Quality of Life Module for Patients With Chronic Myeloid Leukemia